01 The Gateway
Personalised medicine · Genomics

Your gateway to personalised medicine, decoded.

Tricorian Life is the portal to comprehensive, clinically governed genetic testing in Australia. From whole-genome sequencing to targeted clinical panels, we connect you and your loved ones to the right test, the right interpretation, and an ongoing pathway of monitoring and clinical support.

Clinician supervised Privacy & consent first Vetted laboratory partners Longitudinal monitoring
Find the right test Explore the panels
Tradition By appointment
Governance Clinically supervised
Origin Australia

1in 5

Australians carry an actionable PGx variant

95%

of those variants undetected today

6+1pathways

six panels & an oncology pathway

12-24months

monitoring tied to your genome
Our statement of intent

Behind every test, a person. Behind every person, a family. We exist to walk beside both.

Tricorian Life
02 Why Now
Why this matters

Genomics is no longer the future. It is clinical care, now.

Approximately 1 in 5 Australians carries a clinically actionable pharmacogenomic variant. Most are unaware. Tricorian Life is closing that gap by bridging clinical-grade testing, plain-language interpretation, and a longitudinal clinical pathway. One test isn't a result; it is the beginning of a supervised relationship with your genome.

Our principles

Built by Australian clinicians and operators for Australian patients. Independent of pathology providers. Anchored in clinical governance. We do not sell tests; we shepherd people through them.

Independent

No financial ties to any single testing provider. We work with the right partner for each pathway.

Clinically governed

Pathways are clinically governed and accessible through pharmacies, GPs, and specialists, depending on the panel and the clinical question. Reach out and we'll guide you to the right entry point.

Plain language

Every report is translated for the reader, with optional clinical-grade detail for your specialist.

Consent first

No insurance disclosure, no third-party data resale. Your genome is your own.

03 Choose Your Pathway
Choose your platform

Two sequencing pathways. One supervised journey.

Select the depth of insight that fits your goals. Both pathways are clinician-supervised, run by vetted laboratory partners, and integrate directly into a longitudinal monitoring plan.

Option A · Comprehensive

Whole Genome Sequencing

For hereditary insight · Family planning

The most complete view of your DNA. WGS reads every base of your genome, enabling discovery of variants across hereditary cancer, cardiovascular, neurological, metabolic and reproductive domains in a single test. Best for individuals seeking a one-time, lifelong genetic baseline.

  • Hereditary cancer (BRCA1/2, Lynch, PALB2, CHEK2)
  • Cardiovascular & familial hypercholesterolaemia
  • Neurological, metabolic and carrier insights
  • Mandatory genetic counselling & CQC review
  • Cascade testing for at-risk family members
Speak to a clinician
Option B · Focused

Targeted Clinical Panels

For specific questions · Active monitoring

Purpose-built panels for a defined clinical question: pharmacogenomics for safer prescribing, cardiovascular risk stratification, hereditary cancer surveillance, or pre-conception carrier screening. Faster, focused, and ideal for ongoing health monitoring.

  • Pharmacogenomics (PGx) for medication safety
  • Hereditary cancer surveillance panels
  • Cardiovascular & metabolic risk panels
  • Carrier screening with genetic counselling
  • Pathway-aligned escalation to your GP / specialist
Speak to a clinician
Continue reading

Detail & depth.

Below sits the substance of the program: six clinical panels, a dedicated oncology pathway, the journey from sample to insight, and how every result reaches you and your clinicians. If you or someone you love has a health concern, this is where it gets specific, and where you can ask us anything.

Talk to our team Keep reading
04 The Panels
Panel breakdown

Six clinical panels. Plus a dedicated oncology pathway.

Each panel is governed by a defined clinical pathway with structured pre-test information, clinical-grade testing, tiered interpretation, and clear escalation to GPs, specialists or genetic counsellors. Oncology tumour profiling is delivered through a dedicated supported pathway, featured below.

01/06
Pharmacogenomics · PGx

How you metabolise medication

Identify variants that change drug efficacy, dosing or side-effect risk, from antidepressants and statins to anticoagulants and chemotherapy.

Key genes
CYP2D6CYP2C19CYP2C9SLCO1B1DPYDTPMTHLA-B
Entry pathway Pharmacy or clinician
02/06
Hereditary Cancer Risk

Inherited cancer susceptibility

Detect pathogenic variants driving lifetime risk of breast, ovarian, prostate, pancreatic and colorectal cancers. Enables earlier surveillance and cascade testing for family.

Key genes
BRCA1BRCA2PALB2CHEK2ATMMLH1MSH2TP53
Entry pathway Genetic counselling required
03/06
Cardiovascular Genetics

Inherited heart and lipid risk

Identify familial hypercholesterolaemia, elevated lipoprotein(a), and inherited drivers of cardiovascular disease that standard cholesterol testing misses.

Key genes
APOELDLRPCSK9LPA
Entry pathway Pharmacy or clinician
04/06
Neurological & Cognitive

Brain chemistry and mental health

Insight into dopamine metabolism, neuroplasticity, antidepressant response and Alzheimer's susceptibility, informing mental-health prescribing and lifestyle strategy.

Key genes
COMTBDNFSLC6A4APOE-e4
Entry pathway Clinician supervised
05/06
Metabolic & Micronutrients

How your body processes nutrients

Folate metabolism, iron overload risk, vitamin D receptor activity, lactose & coeliac susceptibility, informing nutrition, monitoring and supplementation strategy.

Key genes
MTHFRHFEVDRLCTHLA-DQ2
Entry pathway Pharmacy or clinician
06/06
Reproductive · Carrier

Family-planning carrier screening

For individuals and couples planning to conceive. Identify carriage of inherited conditions including cystic fibrosis, spinal muscular atrophy and fragile X, with mandatory genetic counselling.

Key genes
CFTRSMN1FMR1+250 conditions
Entry pathway Genetic counselling required
Continuous · After any panel

And then, we keep watching.

Your genome is the baseline. We track serial pathology — lipids, glycaemic, hormonal, inflammatory — against your variants over time, giving your clinician the change-detection no single test can provide. One panel is the start. Monitoring is the relationship.

Quarterly Pathology cadence
Variant-anchored Benchmarked to your DNA
GP-shared Full clinician access
Lifelong One relationship, ongoing
05 Oncology Pathway
Awareness & support · For patients and families

When the diagnosis is cancer, you shouldn't face it alone.

A cancer diagnosis ripples through every relationship a patient has. Several molecular testing options can shape the conversation with a treating team, and Tricorian Life exists to help patients and their families understand what's available, what fits their context, and how to access the right pathway. Through our clinical networks we can also facilitate guidance or a second opinion when it's needed most.

For confirmed diagnosis

Tumour profiling

Molecular characterisation of the tumour itself to inform treatment matching, prognosis, and clinical-trial eligibility. Performed after a confirmed cancer diagnosis, ordered through a treating oncologist.

Best for · Treatment matching
Blood-based · ctDNA

Liquid biopsy

A blood test that detects circulating tumour DNA released by cancer cells. Can support early detection in selected contexts, monitor treatment response over time, and surface targeted-therapy options without a fresh tissue biopsy.

Best for · Monitoring · Targeted therapy
Blood-based · markers

Pathology tumour markers

Blood tests that detect proteins or substances released by tumours into the bloodstream. Used as a complementary signal alongside imaging and biopsy, not as a stand-alone diagnostic.

Best for · Complementary insight
Important context

Diagnosis typically requires imaging or biopsy to confirm. These molecular tests inform treatment and monitoring decisions; they do not replace standard diagnostic pathways.

Some tests are covered by Medicare for qualified patients; others sit outside the Medicare schedule and incur out-of-pocket costs depending on eligibility and clinical indication. Reach out and we'll walk you through what may apply to your situation.

Plain language

We translate the science into language patients and their loved ones can use, with each other and with their clinicians.

For families, too

Cancer rarely affects only one person. We make room for the questions partners, parents and children ask, alongside the patient.

Anchored in Australia

Our support is shaped by Australian clinical pathways, language and context, so patients aren't translating advice written for somewhere else.

A steady point of contact

Through diagnosis, decisions and the long stretches in between, we stay a calm and informed presence for the people involved.

Reach out for guidance or a second opinion
06 End to End
Your pathway

From sample to insight, supervised end to end.

Every Tricorian Life pathway runs the same five steps, with clinical governance at every handover. You are never holding a result alone.

01

Intake

Structured eligibility, pre-test information & informed consent.

02

Sample

Buccal swab or blood collection through your pharmacy or pathology partner.

03

Sequence

Vetted laboratory partners delivering clinical-grade variant calling.

04

Interpret

Tiered interpretation: patient, pharmacist and clinician layers.

05

Monitor

Longitudinal pathology tied to your genetic baseline. Always supervised.

07 Three Lenses
Tertiary interpretation

A layered result. Made for every reader.

Genomic results aren't one-size-fits-all. Every report is delivered through three lenses, so you, your pharmacist and your clinician each see exactly what is relevant to them.

Layer 01 · Patient

Plain-language, actionable

A clear, jargon-free summary of what your results mean for you and your family. Risks explained in context, actions explained in steps, with secure portal access to share with the people who care for you.

Layer 02 · Pharmacist

Scope-aligned, navigational

Medication safety alerts, escalation triggers and clinical pathway prompts within pharmacist scope of practice, supporting safer dispensing and informed conversations at the counter.

Layer 03 · Clinician

Variant-level, evidence-referenced

Full clinical-grade interpretation for your GP, specialist or genetic counsellor: variant classifications, evidence references, treatment matching and PGx prescribing guidance.

08 Our Promise

Genetic testing should never be a one-off. It should be the start of a lifelong, clinically supervised relationship with your own DNA, and a means of protecting the people you love.

Clinically governed pathways
Secure data handling
Vetted laboratory partners
HGSA genetic counsellors
09 Common Questions
Frequently asked

What patients ask before they begin.

What is the difference between whole genome sequencing and a targeted panel?

Whole genome sequencing (WGS) reads every base of your DNA. It is the most comprehensive option and is best suited to people seeking a lifelong genetic baseline, family planning insight, or broad hereditary-risk understanding.

Targeted clinical panels read only the genes relevant to a defined clinical question, such as pharmacogenomics, hereditary cancer surveillance, cardiovascular risk, or carrier screening. Panels are typically faster, more focused, and aligned to a specific clinical pathway.

Our clinical team will help you choose the right option for your goals.

Who is genetic testing through Tricorian Life suitable for?

Genetic testing through our pathway is suitable for adults seeking medication safety insight (pharmacogenomics), individuals with a personal or family history of cancer, cardiovascular disease, or inherited conditions, couples planning a family, and people currently navigating a cancer diagnosis who need treatment-informing tumour profiling.

Every pathway begins with a clinical consultation to confirm suitability and informed consent.

How are results explained, and who can see them?

Every report is delivered through three lenses. You receive a plain-language summary you can read at home. Your pharmacist receives a scope-aligned view that supports safer dispensing. Your GP, specialist, or genetic counsellor receives the full clinical-grade interpretation with variant references and evidence levels.

Only the people you consent to share your results with can see them. Your data is never sold, never disclosed to insurers, and never shared with third parties without your explicit consent.

Will my results affect my health or life insurance?

In Australia, life insurers cannot use the results of predictive genetic tests against applicants for cover up to $500,000 (death cover), $500,000 (total permanent disability), and $200,000 (trauma cover), under the Financial Services Council moratorium. You are not required to disclose results to your insurer below those thresholds.

Your results stay private to you and the clinicians you choose to share them with. Tricorian Life never shares genetic data with insurers under any circumstance.

How long does it take to receive results?

Turnaround depends on the panel. Pharmacogenomic and targeted clinical panels typically return within 3 to 4 weeks of sample collection. Whole genome sequencing typically returns within 6 to 8 weeks. Oncology tumour profiling, performed on-shore in Australia, has a faster turnaround appropriate to clinical urgency.

Your clinical team will confirm timing at consultation.

What oncology testing options are available, and which is right for me?

For patients with a cancer diagnosis or context, three molecular options are commonly available: tumour profiling (molecular characterisation of the tumour itself, used for treatment matching, prognosis, and clinical-trial eligibility); liquid biopsy / ctDNA (blood-based detection of circulating tumour DNA, useful for early detection in selected contexts, treatment monitoring, and identifying targeted-therapy options); and pathology tumour markers (blood tests detecting tumour-released substances, used as complementary signals alongside imaging and biopsy).

Diagnosis still typically requires imaging or biopsy to confirm; these molecular tests inform decisions, they do not replace standard diagnostic pathways. Reach out to Tricorian Life to discuss which approach fits your context, or to facilitate a second opinion through our clinical networks.

Is genetic testing covered by Medicare, or are there out-of-pocket costs?

Some tests are covered by Medicare for qualified patients under specific clinical indications (for example, certain hereditary cancer panels for patients meeting eligibility criteria, and several oncology profiling tests when ordered by a treating specialist).

Other tests sit outside the Medicare schedule and incur out-of-pocket costs that vary by lab, panel scope, and clinical context. Pharmacogenomics, broader screening panels, whole-genome sequencing, and most consumer-initiated tests typically fall into this category.

Reach out and we'll talk you through what may apply to your situation before you commit to anything.

How is sample collection done?

Most genetic testing requires a simple buccal (cheek) swab or a small blood draw, which is arranged through your pharmacy or pathology partner. Oncology tumour profiling may additionally require a tissue or liquid biopsy, coordinated through your treating oncologist.

No procedure happens without your informed consent.

What is longitudinal monitoring, and is it required?

Longitudinal monitoring is an optional ongoing service that tracks serial pathology (lipids, glycaemic markers, hormonal, inflammatory) against your genetic baseline, giving your clinician change-detection over time. It is the most powerful way to convert a one-time genetic result into lifelong clinical insight.

It is offered after any panel and can be paused or discontinued at any time.

Start your pathway

Take the first step toward a safer, more personalised future.

Whether you're seeking medication safety, hereditary insight for your family, or a complete genome to anchor a lifetime of monitoring, our clinical team will help you find the right pathway. We respond within 24 hours.

Speak to our clinical team